![](https://d3ilqtpdwi981i.cloudfront.net/hgMLulTppFrqeHaYw4lzq_p42qI=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/40/ab/ab/40abab68-5b75-4304-9d6a-8f639f6eec38/thumbnail_0a2d8994-d8cb-4055-ad53-2826ac042989.jpg)
Article
Divergent Immune Responses and Disease Outcomes in Piglets Immunized with Inactivated and Attenuated H3N2 Swine Influenza Vaccines in the Presence of Maternally-Derived Antibodies
Virology
Document Type
Article
Disciplines
Publication Version
Published Version
Publication Date
9-1-2014
DOI
10.1016/j.virol.2014.06.027
Abstract
Live-attenuated influenza virus (LAIV) prime-boost vaccination previously conferred protection against heterologous H3N2 swine influenza challenge, including in piglets with maternally derived antibodies (MDA). Conversely, a whole-inactivated virus (WIV) vaccine was associated with enhanced disease. This study was aimed at identifying immune correlates of cross-protection. Piglets with and without MDA received intramuscular adjuvanted WIV or intranasal LAIV, and were challenged with heterologous H3N2. WIV induced cross-reactive IgG, inhibited by MDA, and a moderate T cell response. LAIV elicited mucosal antibodies and T cells cross-reactive to the heterologous challenge strain. The presence of MDA at LAIV vaccination blocked lung and nasal antibody production, but did not interfere with T cell priming. Even without mucosal antibodies, MDA-positive LAIV vaccinates were protected, indicating a likely role for T cells. Based on the data, one LAIV dose can induce cell-mediated immunity against antigenically divergent H3N2 influenza virus despite passive antibody interference with humoral immune responses.
Rights
Works produced by employees of the U.S. Government as part of their official duties are not copyrighted within the U.S. The content of this document is not copyrighted.
Language
en
File Format
application/pdf
Citation Information
Matthew Robert Sandbulte, Ratree Platt, James A. Roth, Jamie N. Henningson, et al.. "Divergent Immune Responses and Disease Outcomes in Piglets Immunized with Inactivated and Attenuated H3N2 Swine Influenza Vaccines in the Presence of Maternally-Derived Antibodies" Virology Vol. 464-465 (2014) p. 45 - 54 Available at: http://works.bepress.com/james_roth/34/
This article is from Virology 464-465 (2014): 45, doi:10.1016/j.virol.2014.06.027.